創科實業(00669.HK)2024年純利增長14.9%至11.22億美元
格隆匯3月4日丨創科實業(00669.HK)發佈公告,創科實業於2024年錄得出色的業績,按當地貨幣計算,銷售額增長6.8%至146億美元,自由現金流達到破紀錄的16億美元。按當地貨幣計算,公司的旗艦品牌MILWAUKEE業務銷售額增長11.6%,而RYOBI則增長6.4%。
純利增長14.9%至11.22億美元,反映淨利息支出較2023年減少31.9%。每股盈利亦增加15.1%至61.43美仙。董事會建議派發末期股息每股118.00港仙。
於2024年,毛利率上升85個基點至40.3%。有關增長乃受惠於MILWAUKEE品牌業務增長更高的組合、售後電池銷售,以及跨越公司核心垂直領域新推出的創新產品帶動利潤率上升。此外,公司的世界級生產、營運和採購團隊亦實施了各項生產力措施以節約成本。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.